These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1833220

  • 1. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN.
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [Abstract] [Full Text] [Related]

  • 2. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN.
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [Abstract] [Full Text] [Related]

  • 3. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 5. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 May; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 7. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ, Marshall JF.
    Brain Res; 1989 Nov 20; 502(2):223-32. PubMed ID: 2531015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK, Robertson RG.
    Brain Res; 1994 Mar 21; 640(1-2):185-94. PubMed ID: 8004447
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 21; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173
    [Abstract] [Full Text] [Related]

  • 15. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):273-7. PubMed ID: 2110042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T, Tanji H, Kato H, Itoyama Y.
    J Neurol Sci; 1998 Oct 08; 160(2):121-7. PubMed ID: 9849794
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS, Joyce JN.
    Brain Res Dev Brain Res; 1991 Jun 21; 60(2):105-13. PubMed ID: 1832593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Jun 21; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.